Dr Palace is Consultant Neurologist in Oxford and runs the regional MS service and General neurology for the Banbury area.
She is Lead for the national Congenital Myasthenia service and also runs a joint National Neuromyelitis Service with the Walton Centre Liverpool.
She is a clinical lead for the UK MS risk sharing scheme study assessing the long term effects of beta-interferon and Copaxone.
On Oct 2011 she has published over 80 papers and reviews.
Awards Training and Qualifications
- 1983 BM Honours and Clinical Distinction, SOTON
- 1986 MRCP, SOTON
- 1992 DM, SOTON
- 1995 Accredited Neurology
- 2000 FRCP
BM (Hons) FRCP DM
- Oxford Multiple Sclerosis and Neuromyelitis Group
Neuromyelitus optica, multiple sclerosis and myasthenia
Dr. Palace leads the Oxford Multiple Sclerosis and Neuromyelitis Group. This comprises a regional clinical service and a clinical research group. Research topics include clinical treatment trials, immunological studies, biomarkers and imaging studies on neurodegeneration and its detection and association with inflammation. The group welcomes referrals of patients.
Sources of Funding
An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue
Tackley G. et al, (2021), NeuroImage, 238, 118225 - 118225
Myelin-oligodendrocyte glycoprotein antibody-associated disease
Marignier R. et al, (2021), The Lancet Neurology, 20, 762 - 772
Differential Binding of Autoantibodies to MOG Isoforms in Inflammatory Demyelinating Diseases.
Schanda K. et al, (2021), Neurology(R) neuroimmunology & neuroinflammation, 8
Frequency of MOG-IgG in cerebrospinal fluid versus serum
Pace S. et al, (2021), Journal of Neurology, Neurosurgery and Psychiatry
Sarcoidosis and neuromyelitis optica in a patient with optic neuritis - a case report.
Foster MA. et al, (2021), Ann Clin Transl Neurol